genetracerbiotech.com
BRCA (Full Scheme) accreditation for the European Molecular Genetics Quality Network (EMQN) – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/brca-full-scheme-accreditation-for-the-european-molecular-genetics-quality-network-emqn
Call us 34 942 266 318. Company core: R&D. BRCA (Full Scheme) accreditation for the European Molecular Genetics Quality Network (EMQN). BRCA (Full Scheme) accreditation for the European Molecular Genetics Quality Network (EMQN). This is to certify that Genetracer Biotech has participated in 2015 (Spring) in the following European Molecular Genetics Quality Network (EMQN) external quality assessment schemes:. EMQN Certificateofparticipation2015 Genetracer Biotech. July th28, 2015. Categories: About GTB @en.
genetracerbiotech.com
BRCA 1&2 – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/portfolio-items/hederitariasgen_tracer
Call us 34 942 266 318. Company core: R&D. BRCA2 Sequencing and Analysis. BRCA1 and BRCA2 Coding region sequencing. Whole sequencing of BRCA1 and BRCA2 coding regions. New chemical sequencing solution for false-positives. Bio-data analysis: preprocessing, alignment, data-filtering and quality controls. Detection and annotation of genetic variants. The final clinical will available via secure down-load. Total processing time is estimated between 15 and 30 days according to the size of the samples.
genetracerbiotech.com
Solid Tumor (FFPE_ Liquid Biopsy cfDNA ) – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/portfolio-items/oncogen_tracer
Call us 34 942 266 318. Company core: R&D. Solid Tumor (FFPE Liquid Biopsy cfDNA ). Solid Tumor (FFPE Liquid Biopsy cfDNA ). DNA analysis of solid Tumors (FFPE samples / Liquid Biopsy cfDNA ). ALK, BRAF, EGFR, KRAS, NRAS somatic-gene region sequencing. CE-IVD . Includes FDA and EU approved therapies:. Afatinib, Cetuximab, Dabrafenib, Erlotinib, Gefitinib, Panitumumab, Trametinib, Vemurafenib. New chemical sequencing solution for false-positives. Bio-data Report: identification and analysis of variants.
genetracerbiotech.com
Scientific Committee – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/quienes-somos/comite-cientifico
Call us 34 942 266 318. Company core: R&D. Patient-focused personalized medicine incorporating. Genetic data into clinical and therapeutic analysis. Edificio IBBTEC, c/ Albert Einstein 22 - 39011 Santander, Cantabria, Spain TEL. 34 942 266 318 Contact us.
genetracerbiotech.com
Who we are? – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/quienes-somos
Call us 34 942 266 318. Company core: R&D. Genetracer Biotech is a company that was founded in 2012 by scientists, researchers and Spanish business professionals with in-depth experience in genetic-research and the Spanish business world. Genetracer Biotech makes its patents, translational research from top universities and medical-industry knowledge available to hospital laboratories and research centres from the health, pharmaceutical, bio-tech and food industries. Genetracer Biotech uses its patents, ...
genetracerbiotech.com
Services – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/servicios
Call us 34 942 266 318. Company core: R&D. Health tracer: genetic profile. Analysis of Trasncriptome differential expression Whole Transcriptome Sequencing (WTS). Solid Tumor (FFPE Liquid Biopsy cfDNA ). Solid Tumor (FFPE Liquid Biopsy cfDNA ). Colon, Lung cancer,. ALK, BRAF, EGFR, KRAS. BRCA1 and BRCA2 Coding region sequencing. Ion Ampliseq Exome Kit: rapid and simple method for Exome enrichment. Health tracer: genetic profile. Health tracer: genetic profile. Health tracer: genetic profile.
genetracerbiotech.com
Genetracer Biotech updates its website with a new section: Testimonials – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/genetracer-biotech-actualiza-su-web-con-un-nuevo-apartado-de-testimonios
Call us 34 942 266 318. Company core: R&D. Genetracer Biotech updates its website with a new section: Testimonials. Genetracer Biotech has updated its website with the aim of sharing experiences of their customers regarding services performed. We would like to thank all Genetracer Biotech customers who took time to share their experiences and highlights of working with us. July th27, 2015. Categories: About GTB @en. Para compartir esta historia, elija cualquier plataforma. Leave A Comment Cancel reply.
genetracerbiotech.com
News – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/area-de-prensa
Call us 34 942 266 318. Company core: R&D. On November 6 2015, Genetracer Biotech has participated at the “II Conference of Young Scientists of Cantabria (AJIC)”. November th4, 2015. Categories: About GTB @en. Report on the Genetracer Biotech’s activities that was published in the Annual Report of Innovation in Spain 2015. October th16, 2015. Categories: About GTB @en. Genetracer Biotech has become EQA Assessor Scheme for Lung cancer. October th6, 2015. Categories: About GTB @en. Based on experience gain...
genetracerbiotech.com
Transcriptome (FFPE) – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/portfolio-items/transcriptoma
Call us 34 942 266 318. Company core: R&D. Analysis of Trasncriptome differential expression. Feasible via samples obtained from FFPE and urine. Analysis of human transcriptome differential expressions transcripts included in RefSeq databases can be obtained from a maximum of 10ng RNA (compatible with samples obtained from FFPE). New chemistry of sequencing to help solve false positive problems. Bio-data analysis: analysis of edgeR and DESeq2 genetic differential expression. Altogether, the analysis of t...
genetracerbiotech.com
admin – Genetracer biotech – Medicina estratificada y de precisión
http://genetracerbiotech.com/author/admin
Call us 34 942 266 318. Company core: R&D. This author has not yet filled in any details. So far admin has created 4 blog entries. On November 6 2015, Genetracer Biotech has participated at the “II Conference of Young Scientists of Cantabria (AJIC)”. Report on the Genetracer Biotech’s activities that was published in the Annual Report of Innovation in Spain 2015. Genetracer Biotech has become EQA Assessor Scheme for Lung cancer. On October 1, 2015, Genetracer Biotech has participated at the Ion World Tour.